ROCK2 and breast cancer: In the present study, we first revealed the snoRNA expression profiles in EMT‐activated breast cancer cells and identified a snoRNA that functions as a positive regulator of EMT by upregulating ROCK2 expression in the TGF‐β signaling pathway.